Conversely, the persistence of CD8+ T-cell immune activation might result in a higher incidence of non-AIDS related events (a broad spectrum of cardiovascular, renal, neurocognitive events, and non-AIDS malignancies), that are more common in the lifespan of patients starting ART at low CD4+ T-cell counts, despite effective virologic control and immune recovery. This evidence concerns the gene CD4 and AIDS.